affected by cycloheximide. In the cell-conditioned supernatant, the net result was an increase in PAI-1 activity from 4.18±1.8 to 13.2±6.8 IU/mL 6 hours after the addition of 300 nmol/L Ang II (mean±SD, P'.008, n=6). The Ang IIinduced increase in PAI activity was dose related, with a maximal effect at a concentration of 23 nmol/L (n=3) and an ED50 of 3.3±1.5 nmol/L (n=3). angiotensin II, a specific competitive antagonist of Ang II, blocked 90±9% (n=3) of the PAI activity induced by 10 nmol/L Ang II. In basal conditions, fibrin overlay zymography demonstrated the presence of free TPA. After stimulation with Ang II, lysis caused by the in situ dissociation of TPA was also present in the region of the TPA/PAI-1 complex. Angiotensin I (Ang I) elicited an increase in PAI activity similar to that obtained with equivalent doses of Ang II. Captopril (5 ,ug/mL), an inhibitor of the angiotensin-converting enzyme (ACE), completely prevented the Ang I effect, demonstrating that VSM cells display an ACE-like activity.
Conclusions Recent research has demonstrated the existence of a localized vascular renin-angiotensin system. The finding that Ang II can potentially modulate the plasminogen activation in the arterial wall has important biological and therapeutical implications for the evolution of arterial wall thrombi and the migration of cells through the vessel wall in the genesis of atherosclerotic lesions. We speculate that the reduction in thrombotic events observed in patients with a previous myocardial infarction and in high-renin, hypertensive patients treated with ACE inhibitors could be due at least in part to the decreased production of PAI-1 by VSM 
Fibrin Overlay Zymography
This was performed according to the method of GranelliPiperno and Reich.26 SDS-PAGE was performed using 10% polyacrylamide and 0.1% SDS in 0.383 mol/L Tris, pH 8.8 with a stacking gel containing 5% polyacrylamide, 0.124 mol/L Tris, pH 6.8. After electrophoresis, SDS was removed by washing the gel with water containing 2.5% Triton X-100 followed by a wash in a buffer containing 100 mmol/L NaCl, 50 mmol/L Tris, pH 7.7. The gel then was layered onto a fibrin indicator gel containing 30 ,g/mL of human plasminogen and incubated at 37°C in a humidified atmosphere.
3H-Thymidine and 3H-Amino Acid Incorporation
Preconfluent cultures in 24-multiwell dishes were kept SF for 48 hours. At time 0, after two washes with SF medium, 0.5 mL of SF medium with or without the specified drugs was added to each well. After 20 hours, the cultures were pulsed for 4 hours by adding 0.5 uCi per well of 3H-thymidine. The experiment was terminated by washing twice with 0.9% NaCl, once with 0.5 mL per well of 10% trichloroacetic acid, and twice again with saline. The This method allows the detection of free plasminogen activators. However, even plasminogen activators in complex with PAI-1 can be detected by this method when they are present in relatively large amounts. This is most likely the result of in situ dissociation of the plasminogen activator from the inhibitor in the gel. In control conditions, only TPA was detected, whereas after Ang II treatment, an area of lysis was seen in the region of the TPA/PAI-1 complex (Fig 5) .
PAI-1 and TPA Gene Expression
Ang II stimulation of VSM cell cultures increased PAI-1 and TPA mRNA compared with controls as We and others have previously shown that PDGF can elicit a powerful induction of PAI-1 mRNA and activity in cultured rat aortic VSM cells.14-8 It could then be hypothesized that the Ang IT effect we have observed on PAI-1 and TPA production is indirect, requiring the previous synthesis of PDGF or another protein. The experimental evidence, however, suggests that this is not the case. First, the time courses of the PDGF'4 and Ang II effects on PAI-1 mRNA (Fig 6) are similar, both peaking at around 3 hours. If the Ang IT-induced effect required the previous synthesis of another protein, it would be expected to take substantially longer. Second, the Ang II effect on PAI-1 mRNA was still observed in the presence of the protein synthesis inhibitor cycloheximide (Fig 8) .
The Ang II-induced increase in PAI-1 mRNA correlates well with the increase in PAI activity in the cell-conditioned medium. In the fibrin zymography, an area of lysis, presumably caused by dissociation of TPA, was detected in the region of the TPA/PAI-1 complex after Ang II stimulation. Ang II also induced a dosedependent increase in the TPA mRNA. TPA activity, however, was not detected in measurable amounts in the cell-conditioned medium. This is not entirely surprising in an environment such as the cell-conditioned medium, in which TPA can be readily inactivated by the large amount of PAI-1 present. Fibrin overlay zymography is a more sensitive semiquantitative method to assess plasminogen activator activity. In basal conditions, small amounts of TPA were detected with this method in the cell-conditioned medium. After Ang II stimulation, when PAI activity was markedly increased, TPA also appeared in complex with PAI-1. Taken together, these data demonstrate that in the soluble phase the net Ang II effect was an increase in PAI activity. However, the Ang IT effect on TPA production could play an important role at a local level. Cell migration requires extracellular matrix digestion, and plasminogen activation is an important cellular mechanism in the digestion of extracellular matrix proteins. 37 A "vascular" RAS may profoundly influence medial VSM cells, and the novel finding that these cells produce PAI-1 and TPA in response to Ang I and II has several potential implications. First, the modulation of plasminogen activation in the medial layer of arterial vessels is likely to affect the process of cell migration through it. This could influence the infiltration of inflammatory and tumor cells and also the migration of the VSM cells from the media to the intima during atherogenesis. Second, the lysis of a vessel wall thrombus depends on the amount of plasminogen activators and inhibitors incorporated in the thrombus. The fibrinolytic factors produced at the interface between the clot and the vessel wall could therefore significantly affect the natural or exogenous lysis of arterial thrombi. It can be speculated that if confirmed in vivo, the effect of ACE inhibitors on PAI-1 production by smooth muscle cells could account at least in part for the reduction in cardiovascular events observed in certain patient subsets treated with these agents.
